GDF15 and metabolic syndrome: A recent study by Girona et al. [9] found that higher levels of circulating GDF15 are associated with components of cardiometabolic risk in patients with metabolic conditions, including obesity, metabolic syndrome, diabetes, or cardiovascular disease.